Ben S Cooper
Dados Biográficos
| ID | 9801673 |
|---|---|
| NOME | Ben S Cooper |
| PRENOMES | Ben S |
| SOBRENOME | Cooper |
| ASSINATURA | COOPER B S |
| AFILIAÇÕES | Mahidol University |
| ORCID | 0000-0002-9445-7217 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2000 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
A novel framework for quantifying the clinical impact of substandard and falsified antimicrobials
Substandard and falsified (SF) medicines are a neglected public health threat, with an estimated 7% of antimicrobials in low- and middle-income countries being SF. However, quantifying their clinical impact remains challenging. We developed a general framework for estimating population-level impacts of SF antimicrobials on patient outcomes and apply it to SF fluoroquinolones in typhoid treatment. The framework combines two data sources: published…
Global burden of bacterial antimicrobial resistance 1990–2021
BACKGROUND: Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional publications that provided more detailed estimates for several WHO regions by country. To date, there have been no studies that produce comprehensive estimates of AMR burden across locations that encompass historical trends and future for…
Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand
INTRODUCTION: Thailand was one of the first low- and middle-income countries to publicly fund seasonal influenza vaccines, but the lack of predictability in the timing of epidemics and difficulty in predicting the dominant influenza subtypes present a challenge for existing vaccines. Next-generation influenza vaccines (NGIVs) are being developed with the dual aims of broadening the strain coverage and conferring longer-lasting immunity. However, …
Global burden of bacterial antimicrobial resistance in 2019
BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) a…
The Evolution of Partnerships
In an evolutionary setting, players are allowed to choose not only their strategies for a particular game but also to some extent with whom they will play. This can lead to complex dynamics. Here, simulations are used to obtain some preliminary conclusions. It is shown that the ability to form fixed partnerships can enable players to coordinate on efficient outcomes. In scenarios where partnerships would lead to inefficient outcomes, they do not …
Sem obras proeminentes nesta página.
The Evolution of Partnerships
In an evolutionary setting, players are allowed to choose not only their strategies for a particular game but also to some extent with whom they will play. This can lead to complex dynamics. Here, simulations are used to obtain some preliminary conclusions. It is shown that the ability to form fixed partnerships can enable players to coordinate on efficient outcomes. In scenarios where partnerships would lead to inefficient outcomes, they do not …
Global burden of bacterial antimicrobial resistance in 2019
BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) a…
Global burden of bacterial antimicrobial resistance 1990–2021
BACKGROUND: Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional publications that provided more detailed estimates for several WHO regions by country. To date, there have been no studies that produce comprehensive estimates of AMR burden across locations that encompass historical trends and future for…
Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand
INTRODUCTION: Thailand was one of the first low- and middle-income countries to publicly fund seasonal influenza vaccines, but the lack of predictability in the timing of epidemics and difficulty in predicting the dominant influenza subtypes present a challenge for existing vaccines. Next-generation influenza vaccines (NGIVs) are being developed with the dual aims of broadening the strain coverage and conferring longer-lasting immunity. However, …
A novel framework for quantifying the clinical impact of substandard and falsified antimicrobials
Substandard and falsified (SF) medicines are a neglected public health threat, with an estimated 7% of antimicrobials in low- and middle-income countries being SF. However, quantifying their clinical impact remains challenging. We developed a general framework for estimating population-level impacts of SF antimicrobials on patient outcomes and apply it to SF fluoroquinolones in typhoid treatment. The framework combines two data sources: published…
Biology (4 obras) · Medicine (4 obras) · Microbiology (3 obras) · Antibiotic resistance (2 obras) · Antibiotic Resistance in Bacteria (2 obras) · Antibiotic Use and Resistance (2 obras) · Antibiotics (2 obras) · Antimicrobial (2 obras) · Environmental health (2 obras) · Intensive care medicine (2 obras)